These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 410285)

  • 21. Effects of aspirin-like drugs on Walker 256 tumor growth and cachexia in rats.
    Homem-de-Bittencourt Júnior PI; Pontieri V; Curi R; Lopes OU
    Braz J Med Biol Res; 1989; 22(8):1039-42. PubMed ID: 2633846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of non-steroidal anti-inflammatory drugs on the metabolism of 14C-arachidonic acid by human gingival tissue in vitro.
    Elattar TM; Lin HS; Tira DE
    J Dent Res; 1983 Sep; 62(9):975-9. PubMed ID: 6576002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some factors affecting ouabain-induced ventricular arrhythmia in the reserpine-treated cat.
    Ciofalo F; Levitt B; Roberts J
    Br J Pharmacol Chemother; 1967 May; 30(1):143-54. PubMed ID: 4166977
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).
    Somani P
    Am Heart J; 1969 Jan; 77(1):63-71. PubMed ID: 5782851
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental studies on the effect of prostaglandin and leukotriene synthesis inhibitors on epithelial regeneration of the cornea].
    Rochels R; Busse WD
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(2):74-8. PubMed ID: 6305776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals].
    Amanuma F; Okuyama S; Orikasa S; Hashimoto S; Yamada C; Sakagawa T; Tsutsui Y; Tarumoto Y; Aihara H; Kameyama T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of salicylates on lymphocyte blastogenesis in vitro: association with other non-steroid anti-inflammatory drugs.
    Conti P; Cifone MG; Alesse E; Ianni G; Angeletti PU
    Clin Rheumatol; 1983 Jun; 2(2):127-32. PubMed ID: 6678687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prostaglandins in the arrhythmogenic effects of ouabain on isolated guinea pig hearts.
    Moffat MP; Karmazyn M; Ferrier GR
    Eur J Pharmacol; 1987 Sep; 141(3):383-93. PubMed ID: 3311771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atropine-induced ventricular ectopic arrhythmias and fibrillation.
    Page CP; Deaton WJ; Warren BH; Hoff GE
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):469-77. PubMed ID: 5968524
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of heart rate on the development of ouabain-induced arrhythmias.
    Williams JF; Boyd DL
    Tex Rep Biol Med; 1973; 31(1):79-88. PubMed ID: 4708579
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of inhibition of prostaglandin synthesis in the selection of non-steroidal anti-inflammatory agents.
    Ziel R; Krupp P
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):186-91. PubMed ID: 809368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 35. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
    Mitchell JA; Akarasereenont P; Thiemermann C; Flower RJ; Vane JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11693-7. PubMed ID: 8265610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.
    Rosenstock M; Danon A; Rubin M; Rimon G
    Eur J Pharmacol; 2001 Jan; 412(1):101-8. PubMed ID: 11166741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin synthetase systems of rabbit tissues and their inhibition by nonsteroidal anti-inflammatory drugs.
    Pong SS; Levine L
    J Pharmacol Exp Ther; 1976 Jan; 196(1):226-30. PubMed ID: 812982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between anti-inflammatory properties and inhibition of prostaglandin biosynthesis in vitro.
    Deby C; Descamps M; Binon F; Bacq ZM
    Biochem Pharmacol; 1975 May; 24(10):1089-92. PubMed ID: 808225
    [No Abstract]   [Full Text] [Related]  

  • 39. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
    Burde T; Rimon G
    Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of cyclooxygenase and a receptor-site model for cyclooxygenase.
    Sankawa U; Shibuya M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():319-22. PubMed ID: 2936113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.